Accel retweeted
Today, @washingtonpost covered critical vulnerabilities @depthfirstlabs found in TikTok. These vulnerabilities allowed hackers to access anything on a user’s device that TikTok itself could access, including the camera, microphone, payment information, photos, and the user’s entire TikTok account.
Read more in the thread 🧵
Accel retweeted
Today, @Rentomojo goes public.
An idea about renting became a business that helped India feel at home. We look back at what it took to get here.
Congratulations to the entire team on your IPO and your own new beginning.
#AccelFamily • @prashanthp
Accel retweeted
Agents can now pursue outcomes across long sequences of decisions and interactions, even when nobody knows the correct path in advance. The frontier is making that execution reliable as the environment changes around them.
Every prescription sits at the intersection of a patient, doctor, drug, payer, pharmacy and rules that change constantly. Much of that environment is not legible to software, so finding the right path can require phone calls, faxes, inference and trial and error.
At Forus, every prescription gets its own long-horizon AI agent. As we scale nationally, the challenge is to make these agents generalizable across growing heterogeneity without introducing regressions, while continuing to improve their accuracy, consistency and speed.
I joined @technology to talk about what we’re building and what our $150M Series C unlocks next. We’re hiring engineers in New York to help us put agents in every doctor's office in America.
From a fifteen-year-old in a lobby with his dad, imagining the future, to Salesforce's legal organization working in software he built. Congratulations @MaxJunestrand and @WeAreLegora!
I first came to San Francisco when I was 15, with my dad. He is a programmer. To a teenager from a small island outside of Stockholm, this was the place where the future was being built.
We walked into Salesforce East and stood there watching the enormous digital display of moving water. Outside, Salesforce Tower was starting to rise.
I remember looking up and thinking it would be pretty sweet to have a tower someday. We are not there yet.
What I could not have known is that I would be back years later, having dinner with @Benioff and welcoming @salesforce as a @WeAreLegora customer.
Salesforce's Legal and Corporate Affairs organization will now use Legora across North America, EMEA and APAC. Their lawyers keep the judgment calls. We take care of the work around them. We have run on Slack since day one and became Salesforce customers when our sales team outgrew its first CRM, so it is good to have it run in the other direction too.
Welcome to Legora, Salesforce.
Dad, this one feels special.
Accel retweeted
Incredibly exciting results from @liamfedus and the talented team @periodiclabs who are building at the very edge of what's possible and pushing the frontier. We really are living in an age of miracles
We built high-throughput materials labs in Menlo Park to create a loop between experiments and models. The labs generate fresh data, the models learn from it, and then help us decide what to try next.
Using only 1,300 H200s, plus months of our experimental data, we mid-trained and RL’d an open-source model to surpass GPT-6 Astra on our analysis benchmark. We call it Neon.
This is real footage from our lab. We’re focusing first on hard problems in materials science, including superconductors, magnets, and semiconductor materials.
Read our blog posts below.
Accel retweeted
Tulip promised BIG things.
And we like to deliver.
We present our biggest ever prize-pool for a hackathon: @Accel AI Innovate: Amsterdam.
Over 1 million credits up for grabs.
September 23rd at the AI House. Let’s make it BIG, register below.
lnkd.in/eayMMasH
Accel retweeted
We’re excited to share that @nuance_ai has raised a $50M Series A led by @lightspeedvp, joined by @Accel, @spc, @nvidia, and @definevc!
Much of human communication happens beyond words. Before we can speak, we learn to read faces, return smiles, follow gestures, and sense when someone is listening. That visual and emotional vocabulary stays with us for life.
At Nuance Labs, we’re building a foundation model that understands and responds to the full spectrum of human emotion. A single full-duplex audio-visual model that sees, listens, and responds in real time, with the natural give-and-take of a conversation with a friend or colleague.
We believe the best interface with a machine is the one we’ve practiced since birth.
Join us!
Accel retweeted
@Accel is coming to Amsterdam. On 23 September, Accel AI Innovate brings a one-day hackathon and evening founder conversations with @Lovable’s @FabianHedin and @meetgranola’s @cjpedregal to @Prosusgroup AI House.
The Netherlands has 10.9 AI professionals per 10,000 residents—the highest density among the 15 European country hubs compared in the July 2025 State of AI in the Netherlands report.
For AI builders across the Netherlands: details and separate registration links for the hackathon and evening programme:
dealroom.co/resources/nether…
@yoramdw
Applications for our AI Innovate hackathon in Stockholm with our friends at @Lovable , @polar_sh, KTH AI Society and Hackathon Hub will be closing soon!
If you're a Future Founder who is up for the challenge of building a real product and winning your first customers in a day, apply now: builderbase.com/event/accel-…
Accel retweeted
The **TENTH** largest IT services firm does >$11b revenue annually. The world needs far more software than it can build (and update, and maintain, and monitor, and modernize, etc). @ScottWu46 is building one of the most consequential companies of the AI era
This one feels special - a lot of folks on this list we've admired for years and now finally get to work with.
Above all I'm grateful for the incredible team that we have. Every day at Cog still feels like getting in a room together and trying to build something great.
Also, grateful that Devin is actually good now. Would have looked really dumb otherwise.
BREAKING: Cognition has raised $2B+ at a $48B valuation. @ScottWu46 will be live on TBPN at 12:30p PT to discuss.
Accel retweeted
Forus is a business that gets better as it gets bigger: more access to medicine, more red tape automated away, a more powerful economic engine as the network grows.
And the network is growing, fast.
Congrats @sahirjaggi & team
We’re announcing that Forus has raised a $150M Series C at a $3B valuation to build the AI network for medicine.
Medicine will remain one of the world’s most important industries until humanity achieves immortality, and we are only at the beginning of a new era in what it can do. GLP-1s are changing obesity and cardiometabolic disease. Gene therapies can treat diseases at their genetic source. New cancer treatments are turning diagnoses that were once fatal into diseases people can live with. AI is enabling us to discover of new drugs even faster.
But discovery is only the beginning. It still takes more than a decade and billions of dollars to turn a new molecule into an approved medicine, and once it reaches market, more than a third of patients prescribed specialty treatments never receive their first dose.
Forus is creating the AI network to accelerate the entire medicine pipeline, from development and launch through prescription and treatment. We connect the companies creating medicines with the doctors who prescribe them and the patients who need them.
Today, Forus supports millions of people across all 50 states and is already used by providers to treat patients in 85% of U.S. residential ZIP codes. 9 of the top 15 global biopharma companies work with us, alongside many fast-growing biotechs. Our goal is to put Forus in every doctor’s office in the country and unlock an order of magnitude more medicine for society.
There is a generational opportunity to rethink how new medicine reaches people. Forus is becoming how medicine moves from discovery to treatment in America, and as we scale, we’ll become the most important company in life sciences.
Forus is not constrained by capital or customer demand; we are constrained by the talent and capacity of our team. To take on the opportunity in front of us, we need exceptional engineers and operators in New York who want to move fast and help us make something that matters. Come build with us.
Our Series C was led by Bain Capital Ventures, with Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, and SV Angel investing alongside them.
Accel retweeted
To me @forus represents the very best of what AI will unlock when wielded by the best entrepreneurs. Medicine and how it gets in the hands of patients who need it will be fundamentally changed for the better if @sahirjaggi and team are successful in their mission
We’re announcing that Forus has raised a $150M Series C at a $3B valuation to build the AI network for medicine.
Medicine will remain one of the world’s most important industries until humanity achieves immortality, and we are only at the beginning of a new era in what it can do. GLP-1s are changing obesity and cardiometabolic disease. Gene therapies can treat diseases at their genetic source. New cancer treatments are turning diagnoses that were once fatal into diseases people can live with. AI is enabling us to discover of new drugs even faster.
But discovery is only the beginning. It still takes more than a decade and billions of dollars to turn a new molecule into an approved medicine, and once it reaches market, more than a third of patients prescribed specialty treatments never receive their first dose.
Forus is creating the AI network to accelerate the entire medicine pipeline, from development and launch through prescription and treatment. We connect the companies creating medicines with the doctors who prescribe them and the patients who need them.
Today, Forus supports millions of people across all 50 states and is already used by providers to treat patients in 85% of U.S. residential ZIP codes. 9 of the top 15 global biopharma companies work with us, alongside many fast-growing biotechs. Our goal is to put Forus in every doctor’s office in the country and unlock an order of magnitude more medicine for society.
There is a generational opportunity to rethink how new medicine reaches people. Forus is becoming how medicine moves from discovery to treatment in America, and as we scale, we’ll become the most important company in life sciences.
Forus is not constrained by capital or customer demand; we are constrained by the talent and capacity of our team. To take on the opportunity in front of us, we need exceptional engineers and operators in New York who want to move fast and help us make something that matters. Come build with us.
Our Series C was led by Bain Capital Ventures, with Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, and SV Angel investing alongside them.
The latest from AI healthcare breakout @forus. @sahirjaggi and his team have been growing at a breakneck pace since their Series B earlier this year.
Read more: bloomberg.com/news/articles/…
We’re announcing that Forus has raised a $150M Series C at a $3B valuation to build the AI network for medicine.
Medicine will remain one of the world’s most important industries until humanity achieves immortality, and we are only at the beginning of a new era in what it can do. GLP-1s are changing obesity and cardiometabolic disease. Gene therapies can treat diseases at their genetic source. New cancer treatments are turning diagnoses that were once fatal into diseases people can live with. AI is enabling us to discover of new drugs even faster.
But discovery is only the beginning. It still takes more than a decade and billions of dollars to turn a new molecule into an approved medicine, and once it reaches market, more than a third of patients prescribed specialty treatments never receive their first dose.
Forus is creating the AI network to accelerate the entire medicine pipeline, from development and launch through prescription and treatment. We connect the companies creating medicines with the doctors who prescribe them and the patients who need them.
Today, Forus supports millions of people across all 50 states and is already used by providers to treat patients in 85% of U.S. residential ZIP codes. 9 of the top 15 global biopharma companies work with us, alongside many fast-growing biotechs. Our goal is to put Forus in every doctor’s office in the country and unlock an order of magnitude more medicine for society.
There is a generational opportunity to rethink how new medicine reaches people. Forus is becoming how medicine moves from discovery to treatment in America, and as we scale, we’ll become the most important company in life sciences.
Forus is not constrained by capital or customer demand; we are constrained by the talent and capacity of our team. To take on the opportunity in front of us, we need exceptional engineers and operators in New York who want to move fast and help us make something that matters. Come build with us.
Our Series C was led by Bain Capital Ventures, with Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, and SV Angel investing alongside them.
Accel retweeted
Perplexity will be at RustConf 2026 next week.
@zbraniecki will present “Inside SPACE, the Rust Sandbox Platform Behind Perplexity Computer” on September 10. Then join us for happy hour from 5:30–7:30 PM.
Register at:
pplx.ai/rc-happy-hour
Our AI Innovate series kicks off in Stockholm in just under two weeks. Have you secured your spot at the all-day hackathon with our partners @Lovable , @polar_sh, KTH AI Society and Hackathon Hub?
What are you waiting for? Come with an idea and build a real product in just one day! builderbase.com/event/accel-…
The winning team will receive a Future Founders prize package to take their projects to the next level...
🔴 LIVE From CrowdStrike's Fal.Con 2026 nitter.cf/i/broadcasts/1DGleVwqL…
